Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Ovize

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Critical Care (London, England)|June 4, 2020
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?Martin Cour, Michel Ovize, Laurent Argaud
Circulation Research|August 3, 2013
Myocardial conditioning: opportunities for clinical translationMichel Ovize, Hélène Thibault, Karin Przyklenk
The New England Journal of Medicine|January 7, 2016
Cyclosporine before PCI in Acute Myocardial InfarctionNathan Mewton, Cyrille Bergerot, Michel Ovize
Cardiovascular Research|April 4, 2006
Mitochondrial permeability transition pore and postconditioningOdile Gateau-Roesch, Laurent Argaud, Michel Ovize
Journal of Molecular and Cellular Cardiology|October 5, 2014
Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspectiveMuhammad Rizwan Alam, Delphine Baetz, Michel Ovize
Antioxidants & Redox Signaling|June 29, 2010
Postconditioning in acute myocardial infarction patientsFabrice Ivanes, Gilles Rioufol, Christophe Piot, et al.
Intensive Care Medicine|April 23, 2020
Cyclosporine A prevents cardiac arrest-induced acute respiratory failure: a post-hoc analysis of the CYRUS trialLouis Kreitmann, Laurent Argaud, Michel Ovize, et al.
Disease Models & Mechanisms|January 16, 2010
Postconditioning: from experimental proof to clinical conceptNathan Mewton, Fabrice Ivanès, Martin Cour, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Infarct size reduction in patients with STEMI: why we can do it!Nathan Mewton, Meier Elbaz, Christophe Piot, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 5, 2006
Brain death does not change epicardial action potentials and their response to ischemia-reperfusion in open-chest pigsGeorges Christé, Guylaine Hadour, Michel Ovize, et al.
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Critical Care (London, England)|June 4, 2020
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?Martin Cour, Michel Ovize, Laurent Argaud
Circulation Research|August 3, 2013
Myocardial conditioning: opportunities for clinical translationMichel Ovize, Hélène Thibault, Karin Przyklenk
The New England Journal of Medicine|January 7, 2016
Cyclosporine before PCI in Acute Myocardial InfarctionNathan Mewton, Cyrille Bergerot, Michel Ovize
Cardiovascular Research|April 4, 2006
Mitochondrial permeability transition pore and postconditioningOdile Gateau-Roesch, Laurent Argaud, Michel Ovize
Journal of Molecular and Cellular Cardiology|October 5, 2014
Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspectiveMuhammad Rizwan Alam, Delphine Baetz, Michel Ovize
Antioxidants & Redox Signaling|June 29, 2010
Postconditioning in acute myocardial infarction patientsFabrice Ivanes, Gilles Rioufol, Christophe Piot, et al.
Intensive Care Medicine|April 23, 2020
Cyclosporine A prevents cardiac arrest-induced acute respiratory failure: a post-hoc analysis of the CYRUS trialLouis Kreitmann, Laurent Argaud, Michel Ovize, et al.
Disease Models & Mechanisms|January 16, 2010
Postconditioning: from experimental proof to clinical conceptNathan Mewton, Fabrice Ivanès, Martin Cour, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Infarct size reduction in patients with STEMI: why we can do it!Nathan Mewton, Meier Elbaz, Christophe Piot, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 5, 2006
Brain death does not change epicardial action potentials and their response to ischemia-reperfusion in open-chest pigsGeorges Christé, Guylaine Hadour, Michel Ovize, et al.
Pageof 22